LobbyingEndocrine Society lobbying by quarter
Endocrine Society's latest lobbying report covers Q3 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q3 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Endocrine Society
- Latest quarter
- $0
- Q3 2026 · 1 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $0 | 1 |
| Q4 2022 | $30K | 2 |
| Q1 2023 | $30K | 2 |
| Q2 2023 | $30K | 2 |
| Q3 2023 | $30K | 2 |
| Q4 2023 | $30K | 2 |
| Q1 2024 | $30K | 2 |
| Q2 2024 | $30K | 2 |
| Q3 2024 | $30K | 2 |
| Q4 2024 | $30K | 2 |
| Q1 2025 | $30K | 2 |
| Q2 2025 | $30K | 2 |
| Q3 2025 | $30K | 2 |
| Q4 2025 | $30K | 2 |
| Q1 2026 | $30K | 2 |
| Q2 2026 | $30K | 2 |
| Q3 2026 | $0 | 1 |
Policy issues the reports name
- Health issues20 reports
- Budget and appropriations6 reports
- Medicare and Medicaid5 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE28 reports
- HOUSE OF REPRESENTATIVES25 reports
- Food & Drug Administration (FDA)18 reports
- Centers For Disease Control & Prevention (CDC)17 reports
- Health & Human Services, Dept of (HHS)17 reports
- Natl Institutes of Health (NIH)17 reports
Firms it paid
| Firm | ||
|---|---|---|
| Cavarocchi Ruscio Dennis Associates | $450K | 15 quarters |
| In-houseEndocrine Society | $0 | 17 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ERIKA MILLER | Intern, Rep. Steve Rothman | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 10/01for Q3 | In-house | Under $5,000 |
| 09/24for Q1 2025 | Cavarocchi Ruscio Dennis Associates | $30K |
| 08/07for Q2 | In-house | Under $5,000 |
| 07/16for Q2 | Cavarocchi Ruscio Dennis Associates | $30K |
| 06/29for Q1 | In-house | Under $5,000 |
| 04/20for Q1 | Cavarocchi Ruscio Dennis Associates | $30K |
| 04/14for Q1 | In-house | Under $5,000 |
| 02/11for Q4 2025 | In-house | Under $5,000 |
| 01/20for Q4 2025 | Cavarocchi Ruscio Dennis Associates | $30K |
| 25/10/20for Q3 2025 | In-house | Under $5,000 |
| 25/10/17for Q3 2025 | Cavarocchi Ruscio Dennis Associates | $30K |
| 25/07/18for Q2 2025 | Cavarocchi Ruscio Dennis Associates | $30K |
| 25/07/02for Q2 2025 | In-house | Under $5,000 |
| 25/04/18for Q1 2025 | Cavarocchi Ruscio Dennis Associates | $30K |
| 25/04/01for Q1 2025 | In-house | Under $5,000 |
| 25/01/17for Q4 2024 | Cavarocchi Ruscio Dennis Associates | $30K |
| 25/01/07for Q4 2024 | In-house | Under $5,000 |
| 24/11/05for Q3 2024 | In-house | Under $5,000 |
| 24/10/18for Q3 2024 | Cavarocchi Ruscio Dennis Associates | $30K |
| 24/08/06for Q2 2024 | In-house | Under $5,000 |